Healthcare & Life Sciences
Gritstone Bio
United Statesgritstonebio.com/
Gritstone Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Gritstone Bio
Gritstone Bio is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Gritstone Bio develops immunotherapies that use multi-specific antibodies to target tumor cells by recognizing unique HLA-peptide complexes, aiming to stimulate durable immune responses in cancer patients.
Explore Gritstone Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.